{"coverage_note":"Five discrepancy categories were checked for walgreens.com: (1) Pricing \u2014 a significant verified finding was present: a documented two-tier pricing scheme for generic prescriptions (insured vs. PSC cash price) confirmed by a $100 million federal class action settlement with preliminary approval in November 2024. (2) Availability \u2014 no online-specific discrepancy found; search surfaced only in-store shelf/register price mismatch issues (Vermont AG settlement, San Diego County DA resolution) unrelated to the online checkout flow. (3) Identity \u2014 no finding; no credible evidence of merchant-of-record ambiguity or hidden counterparty issues on the platform. (4) Policy \u2014 no finding; Walgreens' return policy contains broad discretionary carve-outs but these are openly disclosed, and no regulatory enforcement gap was found. (5) Undisclosed constraints \u2014 a confirmed transactional block was found: DEA Schedule II controlled substances cannot be ordered online and this restriction is not surfaced at the point of ordering, only in a buried FAQ, meaning an agent could initiate an order that is impossible to complete without warning.","human_handoff_required_for":[{"action":"Insured prescription checkout where the displayed insurance co-pay price exceeds the current Walgreens Prescription Savings Club (PSC) or other discount program price for the same generic drug \u2014 agent must stop and present both prices to the user before finalizing payment, as the insured price may be artificially inflated relative to the lowest available price at that pharmacy.","evidence":[{"description":"A federal class action alleged that Walgreens charged insured customers inflated 'usual and customary' prices for generic drugs while simultaneously offering lower PSC cash prices, resulting in a $100 million settlement that received preliminary court approval in November 2024.","reference":"https://www.classaction.org/news/walgreens-100m-usual-and-customary-prescription-pricing-class-action-settlement-gets-preliminary-approval"}],"last_checked_date":"2026-07-01"},{"action":"Prescription refill attempt for a DEA Schedule II controlled substance (e.g., Adderall, methylphenidate, opioid analgesics such as oxycodone) initiated through the walgreens.com online platform \u2014 agent must immediately stop the online transaction, notify the user that online ordering is categorically blocked for Schedule II drugs, and direct the user to present the original physical prescription in person at a Walgreens pharmacy location.","evidence":[{"description":"Walgreens' online pharmacy platform does not surface at the point of ordering that DEA Schedule II controlled substances are entirely ineligible for online or phone-approval refills; this restriction is disclosed only in a buried FAQ help page, creating a hard block mid-transaction for agents managing a user's prescriptions.","reference":"https://www.walgreens.com/topic/pharmacy/pharmacy-faq.jsp"}],"last_checked_date":"2026-07-01"}],"record_verification":{"last_checked_agentic_scan":"2026-07-01","last_checked_human_verified":null},"vendor_id":"walgreens","verified_discrepancies":[{"actuals":"Walgreens simultaneously operated a Prescription Savings Club (PSC) offering the same generic drugs at dramatically lower prices to cash-paying customers, while reporting the higher inflated U&C price to third-party payors \u2014 meaning insured customers were systematically charged more than the actual lowest available price. A $100 million class action settlement received preliminary court approval in November 2024, with a final approval hearing scheduled for September 10, 2025.","discrepancy_start_date_est":"Approximately 2007 (when Walgreens introduced the PSC program); litigation active through at least 2025","evidence":[{"description":"CNBC reports Walgreens agreed to pay $100 million to resolve a federal class action lawsuit alleging insured customers were overcharged for generic drugs relative to the lower PSC club prices, filed in U.S. District Court in Chicago.","reference":"https://www.cnbc.com/2024/11/04/walgreens-agrees-to-pay-100-million-to-resolve-lawsuit-over-generic-drug-pricing.html"},{"description":"ClassAction.org details the $100M settlement receiving preliminary approval from Judge Edmond E. Chang on November 18, 2024, citing violations of Illinois Consumer Fraud and Deceptive Business Practices Act and California consumer protection laws.","reference":"https://www.classaction.org/news/100m-walgreens-settlement-aims-to-resolve-lawsuit-over-allegations-of-inflated-generic-drug-prices"}],"interim_guidance":"When completing prescription drug transactions on walgreens.com for insured users, an agent should explicitly compare the displayed insurance co-pay price against the current Walgreens Prescription Savings Club price for the same drug before finalizing checkout. If the PSC or any discount program price is lower, flag this to the user before completing the transaction, as the advertised insured price may not reflect the lowest available price at point of sale.","last_checked_date":"2026-07-01","status":"remediation_claimed_not_reverified","type":"pricing_discrepancy","vendor_claim":"Walgreens advertises and charges insured customers a 'usual and customary' (U&C) price for generic prescription drugs, which is represented to insurers and pharmacy benefit managers as the standard retail price."},{"actuals":"Schedule II controlled substances (DEA-classified drugs such as morphine-like or amphetamine-like medications, including commonly prescribed drugs like Adderall and opioid analgesics) cannot be ordered online or approved over the phone at all. An agent initiating a refill for such a prescription through the online account will discover this block only after attempting to place the order. The original physical prescription must instead be presented in person at the store. This restriction is disclosed only in a buried FAQ help page, not surfaced at the point of ordering or on the prescription listing itself.","discrepancy_start_date_est":"Unconfirmed; policy appears to be long-standing based on DEA regulatory requirements, but disclosure placement has not improved as of July 2026","evidence":[{"description":"Walgreens' own Pharmacy Resources Help page states that Schedule II controlled substances 'may not be ordered online or approved over the phone' and that 'Walgreens.com cannot process online orders of Schedule II Controlled Substances for in-store pickup \u2014 your prescription must be presented in-store.'","reference":"https://www.walgreens.com/topic/help/pharmacyhelp/pharmacy_reference_help_main.jsp"}],"interim_guidance":"Before initiating any prescription refill through walgreens.com, verify whether the medication is a DEA Schedule II controlled substance. If it is (e.g., amphetamines, methylphenidate, opioid analgesics), do not attempt an online order \u2014 the transaction will be blocked. Instead, direct the user to present the original prescription in person at their local Walgreens pharmacy, or contact the pharmacy directly by phone to arrange the pickup.","last_checked_date":"2026-07-01","status":"active","type":"undisclosed_constraint_discrepancy","vendor_claim":"Walgreens.com presents an online pharmacy platform where users can manage and refill their prescriptions digitally, implying that prescriptions visible in a patient's online account can be ordered through the platform."}]}